Canadian CDMO adds spray drying to support ‘poorly soluble drugs’

By Flora Southey

- Last updated on GMT

Genvion has invested approximately $1.5m in spray drying and coating technology for solid dosage forms at its manufacturing facility in Canada.

The contract development and manufacturing organisation (CDMO) has added on-line spray dryers and Wurster coaters to its 80,000 sq. ft. site in Winnipeg, Manitoba.

The investment will see the firm offer spray drying services in R&D and manufacturing for commercial production.

According to Genvion, the investment responds to increased demand for spray drying and drug layering services.

“Customer demand for GMP (good manufacturing practice) spray drying is increasing because of the need to support poorly soluble drugs,” ​said vice president Tony Cocci in a statement.

“Market response to the investment in our capabilities has been very encouraging,” ​he added.

Related news

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us


View more